Canada's medical device market is rigorously regulated to ensure the safety and effectiveness of products used by patients and healthcare professionals. For any entity looking to import medical devices into Canada, understanding and adhering to Health Canada's Medical Devices Regulations (SOR/98-282) is paramount. This detailed article will guide you through the essential procedures for importing medical devices, from classification to licensing and ongoing compliance requirements.

Understanding the Scope: When Do These Regulations Apply?

The Medical Devices Regulations apply to the sale and advertising for sale of a medical device, as well as the importation of a medical device for sale or for use on individuals, excluding importation for personal use. This means that any business intending to bring medical devices into Canada for commercial purposes must navigate these regulations.

Step 1: Medical Device Classification – The Foundation of Regulation

The first critical step in the import process is to accurately classify your medical device. Medical devices in Canada are categorized into one of four classes, based on their inherent risk level, with Class I representing the lowest risk and Class IV representing the highest risk. If a device could fit into more than one class, the class representing the higher risk always applies.

The classification rules are detailed in Schedule 1 of the regulations and consider factors such as how invasive the device is, whether it's active, and its intended use.

Here’s a general overview of classification:

• Invasive Devices:
  • Surgically invasive devices are generally Class II, but can be Class III (if remaining in the body for at least 30 consecutive days or absorbed) or Class IV (if diagnosing, monitoring, controlling, or correcting defects of the central cardiovascular system, central nervous system, or a fetus in utero).
  • Other invasive devices penetrating body orifices or contacting the eye are typically Class II, with exceptions for lower-risk applications (e.g., devices placed in oral/nasal cavities or ear canal, which are Class I) or higher-risk ones (e.g., remaining in the body for 30+ days, which are Class III, or preventing STD transmission, also Class III).
  • Specific items like denture materials, orthodontic appliances, and latex condoms are Class II, while surgical or dental instruments are Class I.
• Non-invasive Devices:
  • Those intended for contact with injured skin are typically Class II, but can be Class I if used as a mechanical barrier, for compression, or for absorption of exudates.
  • Devices for channelling or storing gases, liquids, tissues, or body fluids for introduction into the body are Class II.
  • Devices modifying the biological or chemical composition of blood or other body fluids are generally Class III, but can be Class IV if a potentially hazardous foreign substance is introduced, or Class II if modification occurs via methods like centrifugation or gravity filtration.
  • Most other non-invasive devices are Class I, unless they act as a calibrator, tester, or quality control support for another medical device, or are connected to an active device of Class II, III, or IV, in which case they become Class II.
• Active Devices:
  • Devices emitting ionizing radiation are generally Class III, but can be Class II if used in radiographic mode or Class III for mammographies.
  • Active therapeutic devices for administering or withdrawing energy from the body are Class II, becoming Class III if potentially hazardous, and Class IV if they control treatment via a closed-loop system.
  • Active diagnostic devices for imaging or monitoring physiological processes are Class II, moving to Class III if erroneous readings could cause immediate danger.
  • Active devices for administering or withdrawing drugs, body fluids, or other substances are typically Class II, potentially Class III or Class IV based on risk and complexity (e.g., closed-loop systems).
  • Any other active device falls under Class I.
• Special Rules: These include specific classifications for devices like breast implants (Class IV), and rules for devices manufactured from human or animal tissues (Class IV), or those for disinfecting blood/tissues (Class IV).
• In Vitro Diagnostic Devices (IVDDs): Have their own set of classification rules based on their intended use, such as detecting transmissible agents (Class IV for transfusion suitability, Class II/III/IV based on risk of propagation or severity), patient management (Class II/III), or genetic testing (Class III).

Step 2: Obtaining Necessary Licences

Once your device is classified, you'll need to obtain the appropriate licences to import and sell it in Canada. These generally include a Medical Device Licence (MDL) for the device itself (for Class II, III, and IV devices) and an Establishment Licence (EL) for the importer/distributor.

Medical Device Licence (MDL) for Manufacturers (Class II, III, and IV Devices)

No person shall import or sell a Class II, III or IV medical device unless the manufacturer of the device holds a licence. The MDL is granted to the manufacturer of the device.

Application Process: The manufacturer must submit an application to the Minister of Health, including:

• Device Information: Name, class, and identifier (including for systems, test kits, or device families).
• Manufacturer Details: Name and address as it appears on the label, and the manufacturing establishment's name and address if different.

Class-Specific Additional Requirements:

• Class II Devices: Requires a description of intended uses, a list of complied standards, an attestation from a senior official that the manufacturer has objective evidence meeting safety and effectiveness requirements (sections 10-20), a copy of the device label, and a copy of a Quality Management System (QMS) certificate (CAN/CSA-ISO 13485). For near-patient in vitro diagnostic devices, attestation of investigational testing with human subjects is also required.
• Class III Devices: In addition to general requirements, this includes a description of materials, features for intended use, sales data in other countries (including problems and recalls), a list of design and manufacturing standards, a description of the sterilization method (if applicable), a summary of studies supporting safety and effectiveness, a copy of the label, a summary of investigational testing (for near-patient IVDDs), a bibliography of published reports, and a copy of a QMS certificate (CAN/CSA-ISO 13485).
• Class IV Devices: Demands the most comprehensive documentation, including detailed descriptions of materials and features, international sales history, a thorough risk assessment and quality plan, manufacturing process details, specifications of materials, detailed information on all studies (pre-clinical, clinical, process validation, software validation, literature), objective evidence of biological safety (if animal/human tissue), detailed investigational testing information (for near-patient IVDDs), summaries of all studies and testing, a bibliography, a copy of the label, and a copy of a QMS certificate (CAN/CSA-ISO 13485).

Quality Management System (QMS) Certificate: This certificate confirms that the manufacturer's QMS meets the requirements of the National Standard of Canada CAN/CSA-ISO 13485. The Minister recognizes registrars who have sufficient expertise and conduct audits according to ISO 8402:1994 guidelines. The certificate is valid for a period not exceeding three years.

Foreign Manufacturers: Manufacturers from countries with recognized regulatory authorities and conformity assessment bodies may be exempt from submitting all detailed documents, provided their application includes a certificate of compliance and a supporting summary report.

Issuance and Amendments: The Minister issues an MDL if the device meets safety and effectiveness requirements, and may impose terms and conditions. Amendments are required for "significant changes" to Class III or IV devices, changes in device class, manufacturer or device name, identifier, or intended use for Class II devices (excluding decorative contact lenses).

Refusal: The Minister may refuse an MDL if regulations are not complied with, false statements are made, labelling requirements are not met, or additional requested information/samples are not provided. The Minister shall refuse if the device does not meet safety and effectiveness requirements or if information is insufficient to make that determination.

Establishment Licence (EL) for Importers and Distributors

Generally, no person shall import or sell a medical device unless they hold an establishment licence. This applies to both importers and distributors.

Exemptions to the EL Requirement:

• Retailers.
• Health care facilities.
• Manufacturers of Class II, III, or IV medical devices.
• Manufacturers of Class I devices, if they import or distribute solely through a person who holds an establishment licence.

Importer's Responsibility: An importer must ensure that the person they import from holds an establishment licence, unless importing from the manufacturer of a Class I device (if the importer holds an EL) or from the manufacturer of a Class II, III, or IV device.

Application Process: An application for an EL must be submitted to the Minister and include:

• Establishment Details: Name, address, and any previous names used.
• Contact Person: Name, title, and contact information of a representative.
• Activity Type: Statement indicating whether the activity is importation, distribution, or both.
• Manufacturer Information: Names and addresses of the manufacturers whose devices are being imported or distributed.
• Device Details: Medical specialties (for non-decorative contact lenses) and classes of devices for each manufacturer.
• Documented Procedures Attestation: A senior official must attest that the establishment has documented procedures for:
  • Distribution records, complaint handling, and recalls.
  • For importing Class I devices: procedures for incident reporting (subsections 59(1) and (1.1)).
  • For importing/distributing Class II, III, or IV devices: procedures for incident reporting (subsection 59(1)), provision of information on serious risk of injury (section 61.2), and, if applicable, for handling, storage, delivery, installation, corrective action, and servicing.
• Building Addresses: Addresses of all buildings where these procedures are implemented.

Issuance, Annual Review, and Amendments: The Minister issues an EL if the application meets the requirements. EL holders must submit an annual review application before April 1 each year. Terms and conditions may be imposed or amended at any time.

Refusal and Suspension/Cancellation: The Minister may refuse an EL for false statements, and shall refuse if issuing it would pose a risk to health or safety. Licences can be suspended or cancelled for non-compliance, false statements, failure to meet conditions, or if continuation poses a risk to health or safety.

Medical Devices for an Urgent Public Health Need (UPHN) or Special Access

For devices needed for an urgent public health need (UPHN medical devices) or for special access (emergency use, failed/unavailable/unsuitable conventional therapies), specific authorization pathways exist that may bypass some general Part 1 requirements. These pathways have their own application and post-market requirements.

Step 3: Ensuring Compliance with Safety, Effectiveness, and Labelling

Beyond licensing, all medical devices imported into Canada must comply with stringent safety, effectiveness, and labelling requirements.

Safety and Effectiveness Requirements (Sections 10-20)

Manufacturers are responsible for ensuring their medical devices are designed and manufactured to be safe and effective. This involves:

• Risk Management: Identifying, eliminating, and reducing inherent risks, and providing information on any remaining risks.
• Performance: Ensuring the device performs as intended and is effective for its specified conditions and uses.
• Durability: Characteristics and performance must not deteriorate adversely during the projected useful life under normal use.
• Storage and Transport: Performance must not be adversely affected by transport or storage conditions.
• Material Compatibility: Materials used must be compatible with each other and not pose undue risk.
• Hazard Minimization: Design, manufacture, and packaging must minimize risks from foreseeable hazards (e.g., flammability, contaminants, radiation, electrical/mechanical/thermal hazards, fluid leaks).
• Sterilization: If sold sterile, manufacturing and sterilization must be under controlled conditions, and the method validated.
• System Compatibility: Components of a system must be compatible and not adversely affect overall performance.
• Measuring Functions: Devices with measuring functions must perform within appropriate tolerance limits.
• Software Validation: If the device includes software, it must perform as intended, and its performance must be validated.

Labelling Requirements (Sections 21-23)

No person shall import or sell a medical device unless it has a label containing specific information, which must be legible, permanent, prominent, and easily understood. Key labelling elements include:

• Device Name.
• Manufacturer's Name and Address.
• Device Identifier.
• Control Number: Required for Class III or IV devices.
• Contents: Indication of package contents if not readily apparent.
• Sterility: The word "Sterile" if intended to be sold sterile.
• Expiry Date: If applicable, determined by the manufacturer based on the shortest useful life component.
• Intended Use: Medical conditions, purposes, uses, and performance specifications (unless self-evident).
• Directions for Use: Unless not required for safe and effective use.
• Storage Conditions: Any special conditions.

For devices sold to the general public, information must be on the outside of the package and visible under normal sale conditions. If the package is too small, directions for use can accompany the device. Critically, for devices sold to the general public, certain information (device name, contents, sterility, expiry, intended use, directions, storage) must be provided in both English and French.

Importing Unlabelled Devices: If a medical device is imported for sale without being fully labelled according to regulations, the importer (if holding an EL) or the manufacturer must provide prior notice to the Minister. The manufacturer is responsible for relabelling the device in accordance with regulations within three months of importation and must notify the Minister of the relabeller's name if done by a third party in Canada.

Step 4: Ongoing Post-Market Surveillance and Reporting Obligations

Compliance doesn't end after a device is licensed and imported. Manufacturers and importers have continuous obligations to monitor devices once they are on the Canadian market.

• Distribution Records (Sections 52-56): Manufacturers, importers, and distributors (excluding retailers and healthcare facilities for internal use) must maintain distribution records. These records must contain enough information to allow for a complete and rapid recall of the device and be retained for the longer of the device's projected useful life or two years after shipment.
• Complaint Handling (Sections 57-58): All manufacturers, importers, and distributors (again, excluding retailers and healthcare facilities for internal use) must keep records of reported problems related to device performance or safety (including consumer complaints) and the actions taken in response. They must also establish and implement documented procedures for effective and timely investigation of problems and recalls.
• Incident Reporting (Sections 59-61.1): Manufacturers and importers must submit preliminary and final reports to the Minister for incidents occurring in Canada involving their device if the incident is linked to a device failure, deterioration in effectiveness, or inadequate labelling/directions, and has led to or could lead to death or serious deterioration in health.
  • Preliminary reports are due within 10 days for death/serious deterioration and 30 days for potential serious deterioration. Incidents occurring outside Canada also require reporting if corrective action is intended or required by a foreign regulatory agency.
  • The importer may prepare and submit these reports on the manufacturer's behalf if the information is identical and the Minister is notified.
• Serious Risk of Injury to Human Health (Sections 61.2-61.3): Holders of Medical Device Licences or Establishment Licences (for Class II, III, or IV devices) must submit information regarding any serious risk of injury to human health within 72 hours of receiving or becoming aware of it. This includes risks communicated by other regulatory agencies, labelling changes, and recalls or suspensions in other jurisdictions.
• Summary Reports (Sections 61.4-61.6): MDL holders for Class II devices must prepare biennial summary reports, and for Class III/IV devices, annual summary reports. These reports synthesize information on adverse effects, problems, incidents, and serious risks, and include a critical analysis of whether the known benefits and risks associated with the device have changed. Any changes in benefits or risks must be reported to the Minister in writing within 72 hours. Records of these reports must be maintained for seven years.
• Recalls (Sections 63-65.6): If a manufacturer or importer decides to recall a device (without a Ministerial order), they must inform the Minister in writing within 24 hours of the decision, and provide detailed information before the recall begins. A final report on the recall results and preventive actions must be submitted within 30 days of completion. Detailed records of recalls must be kept for the longer of the projected useful life plus two years, or the period the device is sold in Canada.

How Satori One Click Solutions LLP Can Streamline Your Medical Device Import and Compliance Journey

Navigating the intricate landscape of Health Canada's Medical Devices Regulations can be complex and time-consuming. Satori One Click Solutions LLP can serve as your expert partner, simplifying the process and ensuring seamless compliance every step of the way.

Here's how Satori One Click Solutions LLP can help you obtain your medical device licence and ensure ongoing compliance:

• Expert Medical Device Classification: Satori's specialists can precisely determine the correct risk class (Class I, II, III, or IV) for your medical device by meticulously applying the classification rules outlined in Schedule 1 of the Medical Devices Regulations. This crucial first step ensures all subsequent regulatory actions are correctly aligned.
• Comprehensive Medical Device Licence (MDL) Application Preparation: For Class II, III, and IV devices, Satori can meticulously prepare and submit your MDL applications to Health Canada. This includes:
  • Document Gathering and Review: Compiling all necessary product descriptions, intended uses, lists of standards, study summaries, risk assessments, quality plans, and labels.
  • Quality Management System (QMS) Guidance: Assisting manufacturers in understanding and demonstrating compliance with ISO 13485 (CAN/CSA-ISO 13485) requirements, a mandatory component for Class II, III, and IV MDLs. Satori can guide you through the process of obtaining or validating your QMS certificate from a recognized registrar.
  • Foreign Manufacturer Advantage: Leveraging provisions for foreign manufacturers whose home country regulatory authorities and conformity assessment bodies are recognized by the Minister, potentially streamlining documentation requirements.
  • Responding to Health Canada: Efficiently managing requests for additional information or samples from the Minister, ensuring timely and complete responses to prevent delays or refusals.
• Establishment Licence (EL) Facilitation for Importers and Distributors: For importers and distributors requiring an EL, Satori can:
  • Application Submission: Prepare and submit your EL application, ensuring all required establishment details, activity types, manufacturer information, and documented procedures are correctly presented.
  • Procedure Development: Help develop and document the necessary procedures for distribution records, complaint handling, incident reporting, and recalls, which are essential for EL approval and ongoing compliance.
  • Annual Review Management: Ensure timely submission of annual review applications to maintain your EL in good standing.
• Ensuring Safety, Effectiveness, and Labelling Compliance:
  • Regulatory Gap Analysis: Assessing your device's design, manufacturing, and performance data against Health Canada's safety and effectiveness requirements (sections 10-20) to identify and address any gaps.
  • Labelling Review and Design: Critically reviewing your device labels to ensure they meet all content, legibility, and bilingual requirements (especially for general public sales). Satori can also assist with strategies for importing unlabelled devices and managing the relabelling process within the stipulated timelines.
• Robust Post-Market Surveillance and Reporting Systems: Satori One Click Solutions LLP can implement and manage robust systems for:
  • Distribution Records: Establishing and maintaining compliant distribution records for rapid recalls.
  • Complaint Handling: Setting up documented procedures for investigating problems and managing complaints effectively and promptly.
  • Incident Reporting: Guiding you through the submission of preliminary and final incident reports (Canadian and international incidents) and serious risk of injury notifications within strict timelines, ensuring all required details are accurately captured.
  • Summary Reports: Preparing biennial or annual summary reports for Class II, III, and IV devices, including critical analysis of benefits and risks, and promptly notifying Health Canada of any significant changes.
  • Recall Management: Developing and executing comprehensive recall strategies, handling communications with Health Canada, and ensuring proper record-keeping for both voluntary and ordered recalls.
• Strategic Regulatory Advisory: Beyond transactional services, Satori provides ongoing advisory to keep you informed of regulatory updates and assist with any proposed changes to your device that might require licence amendments.

By partnering with Satori One Click Solutions LLP, you can confidently navigate the Canadian medical device import process, ensuring full regulatory compliance and minimizing risks, allowing you to focus on bringing innovative healthcare solutions to the Canadian market.

Conclusion

Importing medical devices into Canada is a process governed by comprehensive regulations designed to protect public health and safety. From accurate device classification and obtaining the necessary Medical Device Licence and Establishment Licence, to rigorous adherence to safety, effectiveness, and labelling standards, and diligent post-market surveillance, each step requires meticulous attention to detail. Understanding and fulfilling these requirements is key to successfully introducing medical devices to the Canadian market.

Contact Us

Satori One Click Solutions LLP Your Global Partner in Pharma, Medical Devices & Regulatory Compliance

India Office I Canada Office I USA Office

• Email: satoriocs@gmail.com or Info@satoriocs.com
• Website: www.satoriocs.com
• Phone: +91 9829098077